Intero Biosystems wants drugmakers to test on mini human intestines, not animals

Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology. This story matters for Technology readers tracking tech. Reported by techcrunch.com. Read the full original at the source link below.